Self-urinary Infection Testing Market
Market Insights on Self-urinary Infection Testing covering sales outlook, demand forecast & up-to-date key trends
Self-urinary Infection Testing Market : Global Industry Analysis 2016 - 2020 and Opportunity Assessment 2021 - 2031
Self-urinary Infection Testing Market Overview
According to the latest research by Future Market Insights, Self-urinary infection testing market is set to witness a 7.8% growth during the year 2021-2031. The market is expected to witness growth owing to increasing prevalence of urinary tract infections and kidney diseases, surging volume of patients suffering from nephropathic disorders across the globe, increasing prevalence of geriatric population, changing lifestyle of the people.
What is Driving Demand for Self-urinary Infection Testing?
A major factor boosting the growth of the market is the increasing prevalence of UTIs and nephropathic disorders. The lifestyle diseases like hypertension, diabetes, and obesity have an adverse effect on the excretion system, which includes the urinary tract, kidneys, lungs, skin and bladder. It affects the content of urine, appearance, and the concentration, hence leading to different nephropathic disorders.
Moreover, rise in the healthcare expenditure by the government initiatives promotes the affordability of devices, leading to growth sales of urinalysis products, boosting the growth of the market.
Furthermore, technological advancements in the field of self-diagnostics which is expected to boost the development of the market. For instance, in 2019, the federal FDA (Food and Drug Administration) approved a smartphone-based home urine test which allows patients with high-risk pregnancies, chronic diseases or urinary tract infections to observe their health by means of a testing method which is as easy as taking a smartphone selfie.
Increasing Number of UTIs (Urinary Tract Infections) and Nephropathic Disorders Likely to Boost Self-urinary Infection Testing Sales
Self-urinary infection testing industry growth is projected to accelerate in the next five years, boosted by increasing prevalence of UTIs and nephropathic disorders which creates higher demand for different types of urine tests. The rising prevalence of UTIs and nephropathic diseases are caused by lifestyle diseases such as diabetes, hypertension, and obesity which makes an adverse effect on the excretion system, including bladder, urinary tract, and kidney.
A urinary screening program is suggested as an essential element for reducing the incidence of UTIs and kidney diseases which is anticipated to drive the demand for urinalysis test and boost the growth of Self-urinary infection testing market.
US and Canada Self-urinary Infection Testing Market Outlook
The US Self-urinary infection testing market is expected to observe a robust growth in the market owing to high adoption of urinalysis for treatment of the urinary tract infections and liver disease, growth in research activities in the field of urinalysis and rising awareness among the people about urinalysis.
As per the National Diabetes Statics Report in 2017, approximately 30.3 million Americans (nearly 1 in 10) are affected with diabetes. Moreover, rising government initiatives for growing awareness of urinalysis among the people is a key factor boosting the market.
Europe Demand Outlook for Self-urinary Infection Testing
Europe would witness the highest growth after North America because of the rising prevalence of kidney diseases, rising per capita income resulting to better standard of living, rising healthcare spending, increasing demand for improved quality medical care, and rising awareness regarding urinalysis tests in Europe.
In addition, the rise in the incidence of nephropathic disorders and UTIs leads to the increasing demand for the diagnostic system, particularly self-diagnostic, because it is the most rapid growing segment of the diagnostic systems.
Who are the Key Manufacturers and Suppliers of Self-urinary Infection Testing?
Some of the leading manufacturers and suppliers of Self-urinary infection testing include
- Cardinal Health.
- Siemens Healthcare Private Limited
- F. Hoffmann-La Roche Ltd
- Beckman Coulter, Inc.
- Sysmex Middle East FZ-LLC
- Quidel Corporation.
- Bio-Rad Laboratories, Inc.
- ARKRAY, Inc.
- ACON Laboratories, Inc.
- 77 Elektronika Kft
- URIT MEDICAL ELECTRONIC Co., LTD.
- Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
- Healthy.io Ltd
- Q Bio, Inc.
- Scanwell Health, Inc.
- Nova Biomedical
- bioMérieux SA
The global Self-urinary infection testing market is slightly fragmented over the forecast years because of the presence of numerous testing device manufacturers who offer devices such as urinalysis test consumables and systems. Different Self-urinary infection testing device manufacturers are concentrated on developing novel technologies like dipsticks, recently approved mobile based home urine test.
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain.
The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
- Urine Assay Kit
- Creatinine Urine Diagnostic Test Kit
- Home Protein Urine Test Strips
- Kidney Diseases
- Urinary Tract Infections
- Other Diseases
By End User:
- Diagnostic Laboratories
- Hospitals & Clinics
- Home Care Settings
- Assisted Living Healthcare Facilities
- Research Laboratories & Institutes
- North America
- Latin America
- South Asia
- East Asia
- Middle East & Africa